newsfilter
← Latest News
GlobeNewswire·

Belite Bio Announces Oral Presentation at the Retinal Therapeutics Innovation Summit

SAN DIEGO, April 27, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ:BLTE), ("Belite Bio" or the "Company"), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics